Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.

Qiao G, Chen M, Bucsek MJ, Repasky EA, Hylander BL.

Front Immunol. 2018 Feb 6;9:164. doi: 10.3389/fimmu.2018.00164. eCollection 2018. Review.

2.

Plasma interleukin-8 levels are persistently elevated for 1 month after minimally invasive colorectal resection for colorectal cancer.

Shantha Kumara HMC, Sutton E, Bellini GA, Yan X, Rn VC, Gandhi ND, Whelan RL.

Mol Clin Oncol. 2018 Mar;8(3):471-476. doi: 10.3892/mco.2017.1538. Epub 2017 Dec 18.

3.

The Relationship Between Regional Anesthesia and Cancer: A Metaanalysis.

Grandhi RK, Lee S, Abd-Elsayed A.

Ochsner J. 2017 Winter;17(4):345-361. Review.

4.

Factors involved in cancer metastasis: a better understanding to "seed and soil" hypothesis.

Liu Q, Zhang H, Jiang X, Qian C, Liu Z, Luo D.

Mol Cancer. 2017 Dec 2;16(1):176. doi: 10.1186/s12943-017-0742-4. Review.

5.

Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma.

Dickerson EB, Bryan BA.

Vet Sci. 2015 Sep 21;2(3):270-292. doi: 10.3390/vetsci2030270. Review.

6.

Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery.

Angka L, Khan ST, Kilgour MK, Xu R, Kennedy MA, Auer RC.

Int J Mol Sci. 2017 Aug 17;18(8). pii: E1787. doi: 10.3390/ijms18081787. Review.

7.

Patient-derived Interstitial Fluids and Predisposition to Aggressive Sporadic Breast Cancer through Collagen Remodeling and Inactivation of p53.

Kenny TC, Schmidt H, Adelson K, Hoshida Y, Koh AP, Shah N, Mandeli J, Ting J, Germain D.

Clin Cancer Res. 2017 Sep 15;23(18):5446-5459. doi: 10.1158/1078-0432.CCR-17-0342. Epub 2017 Jun 19.

8.

Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model.

Budiu RA, Vlad AM, Nazario L, Bathula C, Cooper KL, Edmed J, Thaker PH, Urban J, Kalinski P, Lee AV, Elishaev EL, Conrads TP, Flint MS.

Cancer Clin Oncol. 2017 May;6(1):12-24. doi: 10.5539/cco.v6n1p12. Epub 2016 Nov 11.

9.

Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer.

Jutagir DR, Blomberg BB, Carver CS, Lechner SC, Timpano KR, Bouchard LC, Gudenkauf LM, Jacobs JM, Diaz A, Lutgendorf SK, Cole SW, Heller AS, Antoni MH.

Breast Cancer Res Treat. 2017 Aug;165(1):169-180. doi: 10.1007/s10549-017-4316-3. Epub 2017 May 30.

PMID:
28560656
10.

Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study.

Jang HI, Lim SH, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS.

Obstet Gynecol Sci. 2017 Mar;60(2):170-177. doi: 10.5468/ogs.2017.60.2.170. Epub 2017 Mar 16.

11.

The C-terminus of IGFBP-5 suppresses tumor growth by inhibiting angiogenesis.

Hwang JR, Cho YJ, Lee Y, Park Y, Han HD, Ahn HJ, Lee JH, Lee JW.

Sci Rep. 2016 Dec 23;6:39334. doi: 10.1038/srep39334.

12.

Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.

Pantziarka P, Bouche G, Sukhatme V, Meheus L, Rooman I, Sukhatme VP.

Ecancermedicalscience. 2016 Oct 12;10:680. eCollection 2016.

13.

The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic Review.

Hefner J, Csef H.

Geburtshilfe Frauenheilkd. 2016 Oct;76(10):1050-1056. Review.

14.

The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases.

Dillekås H, Demicheli R, Ardoino I, Jensen SA, Biganzoli E, Straume O.

Breast Cancer Res Treat. 2016 Jul;158(1):169-78. doi: 10.1007/s10549-016-3857-1. Epub 2016 Jun 15.

15.

Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibition.

Sorski L, Melamed R, Matzner P, Lavon H, Shaashua L, Rosenne E, Ben-Eliyahu S.

Brain Behav Immun. 2016 Nov;58:91-98. doi: 10.1016/j.bbi.2016.05.017. Epub 2016 May 25.

16.

Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.

Choy C, Raytis JL, Smith DD, Duenas M, Neman J, Jandial R, Lew MW.

Oncol Rep. 2016 Jun;35(6):3135-42. doi: 10.3892/or.2016.4710. Epub 2016 Mar 28.

17.

Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug.

Song X, Zhang C, Zhao M, Chen H, Liu X, Chen J, Lonard DM, Qin L, Xu J, Wang X, Li F, O'Malley BW, Wang J.

PLoS One. 2015 Oct 2;10(10):e0140011. doi: 10.1371/journal.pone.0140011. eCollection 2015.

18.

Fundamental Principles of Cancer Biology: Does it have relevance to the perioperative period?

Jiang L, Nick AM, Sood AK.

Curr Anesthesiol Rep. 2015 Sep;5(3):250-256.

19.

Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer.

Watkins JL, Thaker PH, Nick AM, Ramondetta LM, Kumar S, Urbauer DL, Matsuo K, Squires KC, Coleman RL, Lutgendorf SK, Ramirez PT, Sood AK.

Cancer. 2015 Oct 1;121(19):3444-51. doi: 10.1002/cncr.29392. Epub 2015 Aug 24.

20.

Sympathetic nervous system regulation of the tumour microenvironment.

Cole SW, Nagaraja AS, Lutgendorf SK, Green PA, Sood AK.

Nat Rev Cancer. 2015 Sep;15(9):563-72. doi: 10.1038/nrc3978. Review.

Supplemental Content

Support Center